204 related articles for article (PubMed ID: 27746343)
1. Revealing the role of the endocannabinoid system modulators, SR141716A, URB597 and VDM-11, in sleep homeostasis.
Murillo-Rodríguez E; Machado S; Rocha NB; Budde H; Yuan TF; Arias-Carrión O
Neuroscience; 2016 Dec; 339():433-449. PubMed ID: 27746343
[TBL] [Abstract][Full Text] [Related]
2. Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat.
Murillo-Rodríguez E; Vázquez E; Millán-Aldaco D; Palomero-Rivero M; Drucker-Colin R
Eur J Pharmacol; 2007 May; 562(1-2):82-91. PubMed ID: 17336288
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
Seillier A; Giuffrida A
Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B
Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of endocannabinoid metabolism attenuates enhanced hippocampal neuronal activity induced by kainic acid.
Coomber B; O'Donoghue MF; Mason R
Synapse; 2008 Oct; 62(10):746-55. PubMed ID: 18651640
[TBL] [Abstract][Full Text] [Related]
6. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.
Haller VL; Stevens DL; Welch SP
Eur J Pharmacol; 2008 Dec; 600(1-3):50-8. PubMed ID: 18762181
[TBL] [Abstract][Full Text] [Related]
7. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat.
Cross-Mellor SK; Ossenkopp KP; Piomelli D; Parker LA
Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174
[TBL] [Abstract][Full Text] [Related]
8. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats.
Trezza V; Damsteegt R; Manduca A; Petrosino S; Van Kerkhof LW; Pasterkamp RJ; Zhou Y; Campolongo P; Cuomo V; Di Marzo V; Vanderschuren LJ
J Neurosci; 2012 Oct; 32(43):14899-908. PubMed ID: 23100412
[TBL] [Abstract][Full Text] [Related]
9. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
Vlachou S; Nomikos GG; Panagis G
Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the vasorelaxant mechanisms of the endocannabinoid anandamide in rat aorta.
Herradón E; Martín MI; López-Miranda V
Br J Pharmacol; 2007 Nov; 152(5):699-708. PubMed ID: 17704831
[TBL] [Abstract][Full Text] [Related]
11. The administration of endocannabinoid uptake inhibitors OMDM-2 or VDM-11 promotes sleep and decreases extracellular levels of dopamine in rats.
Murillo-Rodríguez E; Palomero-Rivero M; Millán-Aldaco D; Di Marzo V
Physiol Behav; 2013 Jan; 109():88-95. PubMed ID: 23238438
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD.
Fidelman S; Mizrachi Zer-Aviv T; Lange R; Hillard CJ; Akirav I
Eur Neuropsychopharmacol; 2018 May; 28(5):630-642. PubMed ID: 29519609
[TBL] [Abstract][Full Text] [Related]
13. The anandamide membrane transporter inhibitor, VDM-11, modulates sleep and c-Fos expression in the rat brain.
Murillo-Rodríguez E; Millán-Aldaco D; Di Marzo V; Drucker-Colín R
Neuroscience; 2008 Nov; 157(1):1-11. PubMed ID: 18822353
[TBL] [Abstract][Full Text] [Related]
14. Endocannabinoid modulation of male rat sexual behavior.
Gorzalka BB; Morrish AC; Hill MN
Psychopharmacology (Berl); 2008 Jul; 198(4):479-86. PubMed ID: 17694389
[TBL] [Abstract][Full Text] [Related]
15. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
Connell K; Bolton N; Olsen D; Piomelli D; Hohmann AG
Neurosci Lett; 2006 Apr; 397(3):180-4. PubMed ID: 16378681
[TBL] [Abstract][Full Text] [Related]
16. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
[TBL] [Abstract][Full Text] [Related]
18. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
19. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the endogenous cannabinoid system in the effects of alcohol in the mesolimbic reward circuit: electrophysiological evidence in vivo.
Perra S; Pillolla G; Melis M; Muntoni AL; Gessa GL; Pistis M
Psychopharmacology (Berl); 2005 Dec; 183(3):368-77. PubMed ID: 16228194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
